FOLH1 and posterior cortical atrophy: In conclusion, the panelists agreed that PSMA‐PET/CT is the preferred diagnostic modality to detect M1a PCa in both de novo and recurrent setting, but it is currently unknown if improvement in detection leads to better outcomes.